M Maral Mouradian Selected Research

eicosanoyl-5-hydroxytryptamide

12/2018	Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
1/2013	Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Maral Mouradian Research Topics

Disease

34	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2002
13	Synucleinopathies 10/2021 - 08/2009
11	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 06/2002
6	Dementia (Dementias) 01/2022 - 02/2003
6	Dyskinesias (Dyskinesia) 12/2021 - 05/2010
5	Neuroinflammatory Diseases 01/2020 - 01/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 02/2003
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2013 - 07/2006
2	Huntington Disease (Huntington's Disease) 04/2008 - 06/2002
1	Disease Progression 10/2021
1	Ischemic Stroke 01/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2018
1	Tauopathies 01/2018
1	Neoplasms (Cancer) 01/2018
1	Parkinsonian Disorders (Parkinsonism) 06/2015
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2014
1	Hypersensitivity (Allergy) 05/2010
1	Neuroblastoma 05/2009
1	Amyloid Plaque 07/2006
1	Inflammation (Inflammations) 07/2006
1	Multiple System Atrophy 02/2003
1	Brain Neoplasms (Brain Tumor) 07/2002
1	Central Nervous System Diseases (CNS Diseases) 07/2002
1	Multiple Sclerosis 07/2002
1	Nervous System Diseases (Neurological Disorders) 07/2002
1	Viral Encephalitis 07/2002
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 05/2002

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
14	SynucleinsIBA 01/2022 - 05/2011
6	Levodopa (L Dopa)FDA LinkGeneric 12/2021 - 05/2010
6	alpha-SynucleinIBA 11/2019 - 03/2002
5	MicroRNAs (MicroRNA)IBA 01/2020 - 05/2010
4	Dopamine (Intropin)FDA LinkGeneric 10/2019 - 06/2003
3	Protein Glutamine gamma Glutamyltransferase 2IBA 08/2021 - 02/2003
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2016 - 05/2011
3	polyglutamineIBA 04/2008 - 05/2002
2	Biological ProductsIBA 10/2021 - 01/2020
2	MAP Kinase Kinase Kinase 5IBA 01/2020 - 01/2015
2	Protein AggregatesIBA 01/2020 - 07/2006
2	Amyloid (Amyloid Fibrils)IBA 11/2019 - 01/2018
2	Coffee FDA Link 12/2018 - 01/2013
2	eicosanoyl-5-hydroxytryptamideIBA 12/2018 - 01/2013
2	Caffeine (No Doz)FDA LinkGeneric 12/2018 - 01/2013
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018 - 10/2016
2	AntioxidantsIBA 01/2015 - 07/2012
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2013 - 01/2012
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2020
1	Nucleic AcidsIBA 01/2019
1	Leucine (L-Leucine)FDA Link 01/2018
1	EnzymesIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Nalbuphine (Nubain)FDA LinkGeneric 06/2015
1	Narcotic Antagonists (Opioid Antagonists)IBA 06/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015
1	IronIBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	CalciumIBA 01/2013
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 02/2012
1	perampanelIBA 02/2012
1	Serine (L-Serine)FDA Link 05/2011
1	Hormones (Hormone)IBA 05/2009
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 05/2009
1	Estrogen ReceptorsIBA 05/2009
1	LuciferasesIBA 05/2009
1	SteroidsIBA 05/2009
1	PhosphoproteinsIBA 02/2004
1	epsilon-(gamma-glutamyl)-lysineIBA 02/2003
1	TransglutaminasesIBA 02/2003
1	Interferon-betaIBA 07/2002
1	Complementary DNA (cDNA)IBA 07/2002
1	Huntingtin ProteinIBA 06/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2010
2	Deep Brain Stimulation 01/2022 - 01/2022
1	Cell Transplantation 06/2003